Alza says business as usual

Alza Corp. does not anticipate that its planned acquisition by Abbott Laboratories will affect AZA's current drug delivery formulation partnerships other than transferring the benefits to AZA's new parent.

AZA (Palo Alto, Calif.) said the acquisition will not change its current R&D and co-marketing partnerships. "Since Alza will continue to operate as a subsidiary of Abbott, those contracts will remain in place with Alza according to the terms of those contracts," said spokesperson Karen Bergman...